A new Alzheimer’s drug is being hailed as the "beginning of the end" in a search for an effective treatment for the condition.
The drug - called lecanemab - was found to reduce memory decline among patients with early stages of the disease.
This was found in a trial which involved 1,795 participants with early Alzheimer’s, with the drug slowing the disease progression by 27 percent compared with patients taking the placebo.
